Question 1

What does Xencor do?

Accepted Answer

Xencor is a biotechnology company that designs and develops protein-based drugs, including bispecific antibodies, using its proprietary XmAb® protein engineering platform. Their goal is to expand the therapeutic boundaries of antibody drugs and create treatments for cancer and other serious diseases.

Question 2

What is the XmAb protein engineering platform?

Accepted Answer

The XmAb platform is Xencor's proprietary technology that allows them to engineer and optimize antibody and other protein domains, including bispecific antibodies, cytotoxic Fc domains, immune inhibitor Fc domains, and Xtend Fc domains. This platform enables the creation of drug candidates that are tailored to treat specific diseases.

Question 3

Does Xencor have any marketed products?

Accepted Answer

Yes, Xencor has three XmAb-engineered medicines that are marketed by its partners, including Monjuvi® (tafasitamab-cxix) and Ultomiris® (ravulizumab-cwvz).

Question 4

What is Xencor's approach to partnerships?

Accepted Answer

Xencor's XmAb protein engineering platform is designed to be a "plug-and-play" technology, allowing for the substitution of XmAb Fc domains into nearly any antibody. This enables Xencor to engage in a diverse range of partnerships and collaborations, including with companies like Novartis, Amgen, and others, to develop and commercialize novel bispecific antibody therapies.

Xencor

Company Overview

Company Name

Address

Website

Phone

Employees

About Xencor

Frequently Asked Questions about Xencor

What does Xencor do?

What is the XmAb protein engineering platform?

Does Xencor have any marketed products?

What is Xencor's approach to partnerships?

Technologies Used

Key Decision Makers